OpenVSafe by OpenVAERS
Search V-safe

VRG-33885-06386

2 vaccinations 8 coded responses 10 check-ins 8 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
018 / MA
Registered
2021-03-26
Relationship
Self
Race
Other
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-03-26
    Registered in v-safe
  2. 2021-03-26
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-26
    Survey response — day 0, dose 1
    MedDRA: No adverse event — Feeling: Fair · Site: Pain · Fatigue or tiredness
    Free text: No
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-27
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good · Site: Pain
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-28
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-29
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Fair · Fatigue or tiredness, Nausea
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-30
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Fair · Nausea
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-31
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Fair · Fever · Fatigue or tiredness
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-16
    Dose 2 — Pfizer-BioNTech
  11. 2021-07-16
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  12. 2021-10-15
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  13. 2022-04-21
    Survey response — 12 months, dose 2
    MedDRA: COVID-19, Pneumonia — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Covid Pneumonia
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-04-21
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  15. 2022-04-22

Vaccinations

DoseDateManufacturerCo-administered
12021-03-26Pfizer-BioNTech
22021-04-16Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2022-04-21 Unsuccessful

Free text

Release 6 — day 0, dose 1

2021-03-26

Systemic reaction (other): No

Release 6 — days 1–6 daily, dose 1

2021-03-27

Systemic reaction (other): None

2021-03-28

Systemic reaction (other): None

2021-03-29

Systemic reaction (other): None

2021-03-30

Systemic reaction (other): None

2021-03-31

Systemic reaction (other): None

2021-04-01

Systemic reaction (other): None

Release 11 — 12 months, dose 2

2022-04-21

Symptoms: Covid Pneumonia

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDPneumonia · · ✓
SRONo adverse event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release